Colgate-Palmolive director gets stock, option grants
Colgate-Palmolive director Martina Hundmejean received equity awards as part of her annual compensation.
Rhea-AI Filing Summary
Colgate-Palmolive director Martina Hundmejean received equity awards as part of her annual compensation. She was granted 2,075 shares of Common Stock at no cost, credited to a stock unit account under the company’s incentive compensation plan, bringing her direct holdings to 16,206 shares.
She also received a stock option for 2,424 shares of Common Stock with an exercise price of $86.74 per share. The option vests in equal annual installments over three years, starting on the first anniversary of the May 11, 2026 grant date. These are compensation-related grants, not open-market purchases or sales.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 4,499 shares
Grant/Award
2 txns
Insider
HUNDMEJEAN MARTINA
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (Right to Buy) | 2,424 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 2,075 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (Right to Buy) — 2,424 contracts (Direct);
Common Stock — 16,206 shares (Direct)
Footnotes (3)
- F1. Annual director stock grant under the issuer's incentive compensation plan, credited to a stock unit account pursuant to the issuer's incentive compensation plan.
- F2. Annual director stock option grant under the issuer's incentive compensation plan.
- F3. Option becomes exercisable in equal annual installments over three years beginning on the first anniversary of the May 11, 2026 grant date.
Key Figures
Stock grant size: 2,075 shares
Shares held after grant: 16,206 shares
Option grant size: 2,424 options
+2 more
5 metrics
Stock grant size
2,075 shares
Annual director stock grant on May 11, 2026
Shares held after grant
16,206 shares
Common Stock directly held after May 11, 2026 award
Option grant size
2,424 options
Stock Option (Right to Buy) granted May 11, 2026
Option exercise price
$86.74 per share
Exercise price for 2,424-share stock option
Option expiration
May 11, 2034
Expiration date of stock option grant
Key Terms
incentive compensation plan, stock unit account, Annual director stock grant, Annual director stock option grant, +1 more
5 terms
incentive compensation plan financial
"under the issuer's incentive compensation plan, credited to a stock unit account"
An incentive compensation plan is a formal program that rewards employees and executives with bonuses, stock, or other payments tied to specific performance goals—such as revenue, profit, productivity, or long‑term share price. Investors watch these plans because they shape how leaders make decisions and take risks; like paying a coach by wins rather than effort, well‑designed plans can drive sustainable growth while poor designs can encourage short‑term behaviors that harm shareholder value.
stock unit account financial
"credited to a stock unit account pursuant to the issuer's incentive compensation plan"
Annual director stock grant financial
"Annual director stock grant under the issuer's incentive compensation plan"
Annual director stock option grant financial
"Annual director stock option grant under the issuer's incentive compensation plan"
exercisable in equal annual installments financial
"Option becomes exercisable in equal annual installments over three years"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Colgate-Palmolive (CL) director Martina Hundmejean report in this Form 4?
Director Martina Hundmejean reported receiving equity compensation awards, not open-market trades. She was granted 2,075 shares of Common Stock and a stock option covering 2,424 shares, both under Colgate-Palmolive’s incentive compensation plan as part of her annual director compensation.
What are the terms of Martina Hundmejean’s new Colgate-Palmolive (CL) stock option?
She received a stock option for 2,424 shares of Colgate-Palmolive Common Stock with an exercise price of $86.74 per share. The option vests in three equal annual installments beginning on the first anniversary of the May 11, 2026 grant date, according to the disclosure.
Is Martina Hundmejean buying or selling Colgate-Palmolive (CL) stock in this filing?
The filing shows compensation-related acquisitions, not open-market buying or selling. Martina Hundmejean received 2,075 shares and a 2,424-share stock option as annual director grants under Colgate-Palmolive’s incentive compensation plan, rather than executing discretionary purchases or sales in the market.
How is the annual director stock grant for Colgate-Palmolive (CL) structured?
The annual director stock grant is credited to a stock unit account under Colgate-Palmolive’s incentive compensation plan. In this case, Martina Hundmejean received 2,075 Common Stock units plus a separate 2,424-share stock option grant as part of her annual director compensation package.
When do Martina Hundmejean’s new Colgate-Palmolive (CL) options become exercisable?
The stock option becomes exercisable in equal annual installments over three years. Vesting starts on the first anniversary of the May 11, 2026 grant date, meaning portions of the 2,424-share option will vest each year over that three-year period.
AI-generated analysis. How Rhea-AI works. Not financial advice.
